RANKL/OPG provides direct information about the balance between bone formation and resorption and displays a good correlation with the bone fragility maker FGF23, indicating that this parameter is a reliable maker of bone fragility in COVID19 patients and could provide useful and comprehensive information about the inflammation-induce bone loss. The gene discussed is FGF23; the disease is COVID-19.